<DOC>
	<DOCNO>NCT01455454</DOCNO>
	<brief_summary>Coagulopathy transfusion requirement frequent cardiac surgery cardiopulmonary Bypass . Rotational thromboelastrometry ( ROTEM® ) viscoelastic whole blood point care test use assess patient 's coagulation status . The purpose study evaluate feasibility ROTEM® analysis presence high heparin concentration see cardiopulmonary bypass .</brief_summary>
	<brief_title>Heparin 's Influence ROTEM® Analysis</brief_title>
	<detailed_description>The Society Cardiothoracic surgeon suggest 50 % patient undergoing cardiac surgery blood transfusion . Several study indicate increase morbidity mortality relate blood transfusion . Traditionally , coagulation test perform hematology laboratory . Rotational thromboelastrometry useful method assess perioperative coagulation function patient undergoing cardiac surgery . The presence significant amount heparin blood sample cardiopulmonary bypass induces artifactual error thromboplastin use reagent . For reason , whole blood coagulation monitoring ROTEM® feasible cardiopulmonary bypass heparin anticoagulation . Recently recombinant thromboplastin come available . It 's stability guarantee manufacturer plasmatic heparin concentration 5UI/l . Three available ROTEM®-tests EXTEM ( activation recombinant thromboplastin ) , INTEM ( activation elagic acid ) HEPTEM . In latter , heparinase , add INTEM reagent , eliminate heparin reveal underlying coagulopathies . The purpose study evaluate feasibility ROTEM® analysis presence high concentration heparin evaluate whether heparinase could reverse heparin 's effect EXTEM INTEM cardiopulmonary bypass . Arterial blood sample draw analysis induction anesthesia ( T0 ) ,10 minute administration heparin ( T1 ) , unclamping aorta ( T2 ) heparin reversal protamine ( T3 ) . The following test perform : EXTEM , INTEM , HEPTEM heparinase modified EXTEM . For latter , recombinant thromboplatin instead elagic acid use HEPTEM test . Heparin concentration measure T1 end bypass ( T2 ) . HEPCON® use heparin management .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<criteria>Patients ungergoing coronary artery bypass graft use cardiopulmonary bypass Patients 18 85 year old . Patients incapable consent . Known coagulopathies platelet dysfunction . Patients treat antiplatelet drug aspirin . Patients treat anti vitamine K anticoagulant . Patients treat heparin less 6 hour prior surgery .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>October 2011</verification_date>
</DOC>